{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:24Z","timestamp":1790622324752,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["07R-1832"],"award-info":[{"award-number":["07R-1832"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brain Net"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.schres.2016.02.018","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T10:02:02Z","timestamp":1456480922000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study"],"prefix":"10.1016","volume":"177","author":[{"given":"Johann","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Brisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Schiltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Krzy\u017canowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gert","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Gos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainresrev.2006.04.001","article-title":"Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders","volume":"52","author":"Akbarian","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.schres.2016.02.018_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1192\/pb.21.4.224","article-title":"Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications","volume":"21","author":"Atkins","year":"1997","journal-title":"Psychiatr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2016.02.018_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0925-4927(96)03002-8","article-title":"Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia","volume":"67","author":"Becker","year":"1996","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2016.02.018_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2009.06.002","article-title":"Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?","volume":"57","author":"Behrens","year":"2009","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.schres.2016.02.018_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0006-3223(99)00136-5","article-title":"Evidence for altered trisynaptic circuitry in schizophrenic hippocampus","volume":"46","author":"Benes","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","article-title":"Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy","volume":"161","author":"Bernstein","year":"2015","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2016.02.018_bb0040","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/cne.21664","article-title":"Laterodorsal nucleus of the thalamus: a processor of somatosensory inputs","volume":"507","author":"Bezdudnaya","year":"2008","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.schres.2016.02.018_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-3223(93)90289-P","article-title":"Hippocampus\u2013amygdala volumes and psychopathology in chronic schizophrenia","volume":"33","author":"Bogerts","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.018_bb0050","first-page":"47","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2016.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbi.2012.08.005","article-title":"Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?","volume":"26","author":"Busse","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.02.018_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2012.11.001","article-title":"Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses","volume":"255","author":"Carmans","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.schres.2016.02.018_bb0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/appi.ajp.2011.11010052","article-title":"Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features","volume":"168","author":"Curley","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.018_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fncel.2014.00327","article-title":"Shaping inhibition: activity dependent structural plasticity of GABAergic synapses","volume":"8","author":"Flores","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.schres.2016.02.018_bb0075","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/npp.2011.76","article-title":"A novel alpha5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia","volume":"36","author":"Gill","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/mp.2013.152","article-title":"Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects","volume":"19","author":"Glausier","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopsych.2014.05.010","article-title":"Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia","volume":"77","author":"Glausier","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.02.018_bb0090","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/schbul\/sbn070","article-title":"GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia","volume":"34","author":"Gonzalez-Burgos","year":"2008","journal-title":"Schizophr. Bull."},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.02.018_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jad.2008.04.021","article-title":"Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil","volume":"113","author":"Gos","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2016.02.018_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2014.05.012","article-title":"Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients","volume":"41","author":"Gos","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.schres.2016.02.018_bb0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00406-012-0315-x","article-title":"Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil","volume":"262","author":"Gos","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.02.018_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.09.041","article-title":"GABAergic mechanisms of hippocampal hyperactivity in schizophrenia","volume":"167","author":"Heckers","year":"2015","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2016.02.018_bb0115","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1176\/ajp.155.10.1384","article-title":"Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects","volume":"155","author":"Hirayasu","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"4 Suppl.","key":"10.1016\/j.schres.2016.02.018_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"25","key":"10.1016\/j.schres.2016.02.018_bb0125","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1523\/JNEUROSCI.1054-09.2009","article-title":"GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus","volume":"29","author":"Jagasia","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","article-title":"GABA is an effective immunomodulatory molecule","volume":"45","author":"Jin","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.schres.2016.02.018_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/IJTR.S16800","article-title":"Imbalanced kynurenine pathway in schizophrenia","volume":"7","author":"Kegel","year":"2014","journal-title":"Int. J. Tryptophan Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.mcn.2003.10.023","article-title":"Microglia express GABA(B) receptors to modulate interleukin release","volume":"25","author":"Kuhn","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"455","key":"10.1016\/j.schres.2016.02.018_bb0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1198\/016214501753208708","article-title":"Semiparametric regression for clustered data using generalized estimating equations","volume":"96","author":"Lin","year":"2001","journal-title":"J. Am. Stat. Assoc."},{"issue":"5","key":"10.1016\/j.schres.2016.02.018_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2016.02.018_bb0170","first-page":"28","article-title":"The neurophysiology of auditory hallucinations \u2014 a historical and contemporary review","volume":"2","author":"van Lutterveld","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.018_bb0175","series-title":"Atlas of the Human Brain","author":"Mai","year":"2003"},{"key":"10.1016\/j.schres.2016.02.018_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnins.2014.00077","article-title":"Specialized prefrontal \u201cauditory fields\u201d: organization of primate prefrontal-temporal pathways","volume":"8","author":"Medalla","year":"2014","journal-title":"Front. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.02.018_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2014.10.020","article-title":"Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia","volume":"167","author":"Mitchell","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.schres.2016.02.018_bb0195","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2012.04.010","article-title":"Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia","volume":"72","author":"Moyer","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.018_bb0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pnpbp.2012.11.008","article-title":"Anti-inflammatory treatment in schizophrenia","volume":"42","author":"M\u00fcller","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.018_bb0205","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pnpbp.2013.08.008","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","volume":"48","author":"Myint","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-3223(00)01120-3","article-title":"Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects","volume":"50","author":"Narr","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.02.018_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1192\/bjp.bp.109.070441","article-title":"Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study","volume":"196","author":"Nenadic","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.02.018_bb0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-9964(02)00288-8","article-title":"Anterior hippocampal volume reduction in male patients with schizophrenia","volume":"60","author":"Pegues","year":"2003","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2016.02.018_bb0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mp.2013.111","article-title":"Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia","volume":"18","author":"Perez","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.02.018_bb0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.schres.2007.04.034","article-title":"Left posterior hippocampal density reduction using VBM and stereological MRI procedures in schizophrenia","volume":"96","author":"Rametti","year":"2007","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-198904000-00001","article-title":"Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics","volume":"4","author":"Rey","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"42","key":"10.1016\/j.schres.2016.02.018_bb0240","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2016.02.018_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnins.2014.00019","article-title":"The impact of environmental factors in severe psychiatric disorders","volume":"8","author":"Schmitt","year":"2014","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.schres.2016.02.018_bb0255","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archgenpsychiatry.2009.115","article-title":"Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders","volume":"66","author":"Schobel","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2016.02.018_bb0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrn3085","article-title":"A pathophysiological framework of hippocampal dysfunction in ageing and disease","volume":"12","author":"Small","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.schres.2016.02.018_bb0265","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jpsychires.2007.10.001","article-title":"S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study","volume":"42","author":"Steiner","year":"2008","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.schres.2016.02.018_bb0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood\u2013brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.02.018_bb0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology?","volume":"176","author":"Steullet","year":"2016","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2016.02.018_bb0280","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2006.07.033","article-title":"Anatomical evidence of impaired feedforward auditory processing in schizophrenia","volume":"61","author":"Sweet","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2016.02.018_bb0285","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1176\/appi.ajp.160.12.2190","article-title":"Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia","volume":"160","author":"Szeszko","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2016.02.018_bb0290","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1098-2396(199808)29:4<323::AID-SYN4>3.0.CO;2-7","article-title":"Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain","volume":"29","author":"Todtenkopf","year":"1998","journal-title":"Synapse"},{"issue":"7","key":"10.1016\/j.schres.2016.02.018_bb0295","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0006-3223(01)01121-0","article-title":"Selective bilateral hippocampal volume loss in chronic schizophrenia","volume":"50","author":"Velakoulis","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2016.02.018_bb0300","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1073\/pnas.95.9.5341","article-title":"A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia","volume":"95","author":"Woo","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.schres.2016.02.018_bb0305","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.schres.2016.02.018_bb0310","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1152\/jn.00079.2008","article-title":"Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex","volume":"100","author":"Zhang","year":"2008","journal-title":"J. Neurophysiol."},{"issue":"Pt 3","key":"10.1016\/j.schres.2016.02.018_bb0315","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/brain\/aws335","article-title":"Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia","volume":"136","author":"Zierhut","year":"2013","journal-title":"Brain"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T21:29:56Z","timestamp":1536960596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416300743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":63,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0920996416300743"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.02.018","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}